A new daily pill has been approved for patients with a specific type of cancer. This pill is meant for individuals who have not responded to other treatments or cannot undergo traditional therapies. The approval is significant, given the number of people expected to be diagnosed with this cancer this year.

The pill has been shown to extend survival when taken alongside standard chemotherapy. It targets specific mutations that are believed to drive most cases of this cancer.

Further details about this new treatment are available from the source, including information about the manufacturer and the class of drugs it belongs to.